Benzodiazepine Overdose and Withdrawal Are Essentially Never Fatal 2014-11-10 by Zak Fallows CC-BY License, Please Reuse
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
GABA Receptors
D Reviews • BIOTREND Reviews • BIOTREND Reviews • BIOTREND Reviews • BIOTREND Reviews Review No.7 / 1-2011 GABA receptors Wolfgang Froestl , CNS & Chemistry Expert, AC Immune SA, PSE Building B - EPFL, CH-1015 Lausanne, Phone: +41 21 693 91 43, FAX: +41 21 693 91 20, E-mail: [email protected] GABA Activation of the GABA A receptor leads to an influx of chloride GABA ( -aminobutyric acid; Figure 1) is the most important and ions and to a hyperpolarization of the membrane. 16 subunits with γ most abundant inhibitory neurotransmitter in the mammalian molecular weights between 50 and 65 kD have been identified brain 1,2 , where it was first discovered in 1950 3-5 . It is a small achiral so far, 6 subunits, 3 subunits, 3 subunits, and the , , α β γ δ ε θ molecule with molecular weight of 103 g/mol and high water solu - and subunits 8,9 . π bility. At 25°C one gram of water can dissolve 1.3 grams of GABA. 2 Such a hydrophilic molecule (log P = -2.13, PSA = 63.3 Å ) cannot In the meantime all GABA A receptor binding sites have been eluci - cross the blood brain barrier. It is produced in the brain by decarb- dated in great detail. The GABA site is located at the interface oxylation of L-glutamic acid by the enzyme glutamic acid decarb- between and subunits. Benzodiazepines interact with subunit α β oxylase (GAD, EC 4.1.1.15). It is a neutral amino acid with pK = combinations ( ) ( ) , which is the most abundant combi - 1 α1 2 β2 2 γ2 4.23 and pK = 10.43. -
Dynamic Regulation of the GABAA Receptor Function by Redox Mechanisms S
Supplemental material to this article can be found at: http://molpharm.aspetjournals.org/content/suppl/2016/07/20/mol.116.105205.DC1 1521-0111/90/3/326–333$25.00 http://dx.doi.org/10.1124/mol.116.105205 MOLECULAR PHARMACOLOGY Mol Pharmacol 90:326–333, September 2016 Copyright ª 2016 by The American Society for Pharmacology and Experimental Therapeutics MINIREVIEW—A LATIN AMERICAN PERSPECTIVE ON ION CHANNELS Dynamic Regulation of the GABAA Receptor Function by Redox Mechanisms s Daniel J. Calvo and Andrea N. Beltrán González Laboratorio de Neurobiología Celular y Molecular, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular Downloaded from ¨Dr. Héctor N. Torres¨ (INGEBI), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires, Argentina (D.J.C., A.N.B.G.) Received May 15, 2016; accepted July 14, 2016 ABSTRACT molpharm.aspetjournals.org Oxidizing and reducing agents, which are currently involved normally present in neurons and glia or are endogenously in cell metabolism and signaling pathways, can regulate fast generated in these cells under physiologic states or during inhibitory neurotransmission mediated by GABA receptors in the oxidative stress (e.g., hydrogen peroxide, superoxide and hy- nervous system. A number of in vitro studies have shown that droxyl radicals, nitric oxide, ascorbic acid, and glutathione), diverse redox compounds, including redox metabolites and induce potentiating or inhibiting actions on different native and reactive oxygen and nitrogen species, modulate phasic and recombinant GABAA receptor subtypes. Based on these results, it tonic responses mediated by neuronal GABAA receptors through is thought that redox signaling might represent a homeostatic both presynaptic and postsynaptic mechanisms. -
Benzodiazepine & Alcohol Co-Ingestion
The Journal of COLLEGIATE EMERGENCY MEDICAL SERVICES ISSN: 2576-3687 (Print) 2576-3695 (Online) Journal Website: https://www.collegeems.com Benzodiazepine & Alcohol Co-Ingestion: Implications for Collegiate-Based Emergency Medical Services David Goroff & Alexander Farinelli Keywords: alcohol, benzodiazepines, collegiate-based emergency medical services, toxicology Citation (AMA Style): Goroff D, Farinelli A. Benzodiazepine and Alcohol Co-In- gestion. J Coll Emerg Med Serv. 2018; 1(2): 19-23. https://doi.org/10.30542/ JCEMS.2018.01.02.04 Electronic Link: https://doi.org/10.30542/JCEMS.2018.01.02.04 Published Online: August 8, 2018 Published in Print: August 13, 2018 (Volume 1: Issue 2) Copyright: © 2018 Goroff & Farinelli. This is an OPEN ACCESS article distributed under the terms of the Creative Commons Attribu- tion 4.0 International (CC BY 4.0) License, which permits unrestrict- ed use, distribution, and reproduction in any medium, provided the original author and source are credited. The full license is available at: https://creativecommons.org/licenses/by/4.0/ CLINICAL REVIEW Benzodiazepine & Alcohol Co-Ingestion: Implications for Collegiate-Based Emergency Medical Services David Goroff, MS, NRP & Alexander Farinelli, BS, NRP ABSTRACT KEYWORDS: alcohol, The co-ingestion of benzodiazepines and alcohol presents a unique challenge to colle- benzodiazepines, collegiate- giate EMS providers, due to the pharmacological interaction of the two substances and based emergency medical the variable patient presentations. Given the likelihood that collegiate EMS providers services, toxicology will be called to treat a patient who has co-ingested benzodiazepines and alcohol, this Corresponding Author and review discusses the relevant pharmacology, clinical presentation, and treatment of these Author Affiliations:Listed co-ingestion patients. -
Neonatal Clonazepam Administration Induced Long-Lasting Changes in GABAA and GABAB Receptors
International Journal of Molecular Sciences Article Neonatal Clonazepam Administration Induced Long-Lasting Changes in GABAA and GABAB Receptors Hana Kubová 1,* , Zde ˇnkaBendová 2,3 , Simona Moravcová 2,3 , Dominika Paˇcesová 2,3, Luisa Rocha 4 and Pavel Mareš 1 1 Institute of Physiology, Academy of Sciences of the Czech Republic, 14220 Prague, Czech Republic; [email protected] 2 Faculty of Science, Charles University, 12800 Prague, Czech Republic; [email protected] (Z.B.); [email protected] (S.M.); [email protected] (D.P.) 3 National Institute of Mental Health, 25067 Klecany, Czech Republic 4 Pharmacobiology Department, Center of Research and Advanced Studies, Mexico City 14330, Mexico; [email protected] * Correspondence: [email protected]; Tel.: +420-2-4106-2565 Received: 31 March 2020; Accepted: 28 April 2020; Published: 30 April 2020 Abstract: Benzodiazepines (BZDs) are widely used in patients of all ages. Unlike adults, neonatal animals treated with BZDs exhibit a variety of behavioral deficits later in life; however, the mechanisms underlying these deficits are poorly understood. This study aims to examine whether administration of clonazepam (CZP; 1 mg/kg/day) in 7–11-day-old rats affects Gama aminobutyric acid (GABA)ergic receptors in both the short and long terms. Using RT-PCR and quantitative autoradiography, we examined the expression of the selected GABAA receptor subunits (α1, α2, α4, γ2, and δ) and the GABAB B2 subunit, and GABAA, benzodiazepine, and GABAB receptor binding 48 h, 1 week, and 2 months after treatment discontinuation. Within one week after CZP cessation, the expression of the α2 subunit was upregulated, whereas that of the δ subunit was downregulated in both the hippocampus and cortex. -
Emergency Medical Services Program Policies – Procedures – Protocols
Emergency Medical Services Program Policies – Procedures – Protocols Protocols Table of Contents GENERAL PROVISIONS ................................................................................................ 3 DESTINATION DECISION SUMMARY-METRO BAKERSFIELD AREA ........................ 5 DETERMINATION OF DEATH ..................................................................................... 12 101 AIRWAY OBSTRUCTION ...................................................................................... 16 102 ALTERED LEVEL OF CONSCIOUSNESS ............................................................ 18 103 ALLERGIC REACTION/ANAPHYLAXIS ................................................................ 20 104 ASYSTOLE/ PULSELESS ELECTRICAL ACTIVITY ............................................. 22 105 BITES STINGS ENVENOMATION ......................................................................... 24 106 BRADYCARDIA ..................................................................................................... 26 107 BRIEF RESOLVED UNEXPLAINED EVENT ......................................................... 29 108 BURNS ................................................................................................................... 32 109 CHEMPACK ........................................................................................................... 35 110 CHEST PAIN OR ACUTE CORONARY SYNDROME ........................................... 37 111 CHEST TRAUMA .................................................................................................. -
Acute Poisoning: Understanding 90% of Cases in a Nutshell S L Greene, P I Dargan, a L Jones
204 REVIEW Postgrad Med J: first published as 10.1136/pgmj.2004.027813 on 5 April 2005. Downloaded from Acute poisoning: understanding 90% of cases in a nutshell S L Greene, P I Dargan, A L Jones ............................................................................................................................... Postgrad Med J 2005;81:204–216. doi: 10.1136/pgmj.2004.024794 The acutely poisoned patient remains a common problem Paracetamol remains the most common drug taken in overdose in the UK (50% of intentional facing doctors working in acute medicine in the United self poisoning presentations).19 Non-steroidal Kingdom and worldwide. This review examines the initial anti-inflammatory drugs (NSAIDs), benzodiaze- management of the acutely poisoned patient. Aspects of pines/zopiclone, aspirin, compound analgesics, drugs of misuse including opioids, tricyclic general management are reviewed including immediate antidepressants (TCAs), and selective serotonin interventions, investigations, gastrointestinal reuptake inhibitors (SSRIs) comprise most of the decontamination techniques, use of antidotes, methods to remaining 50% (box 1). Reductions in the price of drugs of misuse have led to increased cocaine, increase poison elimination, and psychological MDMA (ecstasy), and c-hydroxybutyrate (GHB) assessment. More common and serious poisonings caused toxicity related ED attendances.10 Clinicians by paracetamol, salicylates, opioids, tricyclic should also be aware that severe toxicity can result from exposure to non-licensed pharmaco- -
Neurochemical Mechanisms Underlying Alcohol Withdrawal
Neurochemical Mechanisms Underlying Alcohol Withdrawal John Littleton, MD, Ph.D. More than 50 years ago, C.K. Himmelsbach first suggested that physiological mechanisms responsible for maintaining a stable state of equilibrium (i.e., homeostasis) in the patient’s body and brain are responsible for drug tolerance and the drug withdrawal syndrome. In the latter case, he suggested that the absence of the drug leaves these same homeostatic mechanisms exposed, leading to the withdrawal syndrome. This theory provides the framework for a majority of neurochemical investigations of the adaptations that occur in alcohol dependence and how these adaptations may precipitate withdrawal. This article examines the Himmelsbach theory and its application to alcohol withdrawal; reviews the animal models being used to study withdrawal; and looks at the postulated neuroadaptations in three systems—the gamma-aminobutyric acid (GABA) neurotransmitter system, the glutamate neurotransmitter system, and the calcium channel system that regulates various processes inside neurons. The role of these neuroadaptations in withdrawal and the clinical implications of this research also are considered. KEY WORDS: AOD withdrawal syndrome; neurochemistry; biochemical mechanism; AOD tolerance; brain; homeostasis; biological AOD dependence; biological AOD use; disorder theory; biological adaptation; animal model; GABA receptors; glutamate receptors; calcium channel; proteins; detoxification; brain damage; disease severity; AODD (alcohol and other drug dependence) relapse; literature review uring the past 25 years research- science models used to study with- of the reasons why advances in basic ers have made rapid progress drawal neurochemistry as well as a research have not yet been translated Din understanding the chemi- reluctance on the part of clinicians to into therapeutic gains and suggests cal activities that occur in the nervous consider new treatments. -
Benzodiazepine (Benzo) Advisory
BENZODIAZEPINE (BENZO) ADVISORY Drug checking within the Interior Health region continues to detect benzodiazepines (benzos) in multiple drug samples in several communities across the region. Benzodiazepines have been found in a variety of substances most often sold as “down”, heroin, or fentanyl. There has been a wide range of colours and textures identified. Risk: Benzodiazepines mixed with opioids carry a high risk of overdose and can cause prolonged sedation, sleepiness, muscle relaxation, slurred speech, loss of consciousness, black outs/memory loss. Overdose Response: Responding to overdoses involving BOTH Opioids and Benzos is more complex. Naloxone does not work on Benzos, BUT naloxone will work on the opioid overdose symptoms. After giving breaths and naloxone, the person may begin breathing normally, but may not wake up. More doses of naloxone should only be given if the person is not breathing normally (less than 10 breaths a minute). If the person is breathing normally but remains unconscious, place in recovery position and stay with them until emergency services arrive. Call to action: Reinforce overdose prevention messaging: don’t use alone, start small – go low and slow, use overdose prevention services. Talk to clients about getting their drugs tested for benzodiazepines. Benzo testing is currently available at the following the locations: o ASK Wellness: Kamloops – 778-257-1292 o Supervised Consumption Service: Kelowna o UBCO Harm Reduction Program: Kelowna, Penticton, Vernon 250-864-1431 o Vernon Overdose Prevention Site: 250-503-3737 o ANKORS: Cranbrook - 250-426-3383 o ANKORS: Nelson - 250-505-5506 o MHSU Overdose Prevention Nurses - Penticton - 250-462-1050 Ensure that service providers and peer responders are aware of how to recognize and respond to overdoses involving benzos. -
Critical Care Nursing of Infants and Children Martha A
University of Pennsylvania ScholarlyCommons Miscellaneous Papers Miscellaneous Papers 1-1-2001 Critical Care Nursing of Infants and Children Martha A. Q. Curley University of Pennsylvania, [email protected] Patricia A. Moloney-Harmon The Children's Hospital at Sinai Copyright by the author. Reprinted from Critical Care Nursing of Infants and Children, Martha A.Q. Curley and Patricia A. Moloney-Harmon (Editors), (Philadelphia: W.B. Saunders Co., 2001), 1,128 pages. NOTE: At the time of publication, the author, Martha Curley was affiliated with the Children's Hospital of Boston. Currently, she is a faculty member in the School of Nursing at the University of Pennsylvania. This paper is posted at ScholarlyCommons. http://repository.upenn.edu/miscellaneous_papers/4 For more information, please contact [email protected]. Please Note: The full version of this book and all of its chapters (below) can be found on ScholarlyCommons (from the University of Pennsylvania) at http://repository.upenn.edu/miscellaneous_papers/4/ Information page in ScholarlyCommons Full book front.pdf - Front Matter, Contributors, Forward, Preface, Acknowledgements, and Contents Chapter 1.pdf - The Essence of Pediatric Critical Care Nursing Chapter 2.pdf - Caring Practices: Providing Developmentally Supportive Care Chapter_3.pdf - Caring Practices: The Impact of the Critical Care Experience on the Family Chapter_4.pdf - Leadership in Pediatric Critical Care Chapter 5.pdf - Facilitation of Learning Chapter_6.pdf - Advocacy and Moral Agency: A Road Map for -
Bicuculline and Gabazine Are Allosteric Inhibitors of Channel Opening of the GABAA Receptor
The Journal of Neuroscience, January 15, 1997, 17(2):625–634 Bicuculline and Gabazine Are Allosteric Inhibitors of Channel Opening of the GABAA Receptor Shinya Ueno,1 John Bracamontes,1 Chuck Zorumski,2 David S. Weiss,3 and Joe Henry Steinbach1 Departments of 1Anesthesiology and 2Psychiatry, Washington University School of Medicine, St. Louis, Missouri 63110, and 3University of Alabama at Birmingham, Neurobiology Research Center and Department of Physiology and Biophysics, Birmingham, Alabama 35294-0021 Anesthetic drugs are known to interact with GABAA receptors, bicuculline only partially blocked responses to pentobarbital. both to potentiate the effects of low concentrations of GABA and These observations indicate that the blockers do not compete to directly gate open the ion channel in the absence of GABA; with alphaxalone or pentobarbital for a single class of sites on the however, the site(s) involved in direct gating by these drugs is not GABAA receptor. Finally, at receptors containing a1b2(Y157S)g2L known. We have studied the ability of alphaxalone (an anesthetic subunits, both bicuculline and gabazine showed weak agonist steroid) and pentobarbital (an anesthetic barbiturate) to directly activity and actually potentiated responses to alphaxalone. These activate recombinant GABAA receptors containing the a1, b2, and observations indicate that the blocking drugs can produce allo- g2L subunits. Steroid gating was not affected when either of two steric changes in GABAA receptors, at least those containing this mutated b2 subunits [b2(Y157S) and b2(Y205S)] are incorporated mutated b2 subunit. We conclude that the sites for binding ste- into the receptors, although these subunits greatly reduce the roids and barbiturates do not overlap with the GABA-binding site. -
Benzodiazepine Overdose
BRITISH MEDICAL JOURNAL VOLUME 290 16 MARCH 1985 805 Br Med J (Clin Res Ed): first published as 10.1136/bmj.290.6471.805 on 16 March 1985. Downloaded from benzodiazepine dependent animals.'2 In man oral Ro 15- Benzodiazepine overdose: 1788 (200 mg) antagonises the effects of diazepam on are antagonists psychomotor performance without decreasing its bio- specific availability'3"' and reverses the benzodiazepine effects on useful? rapid eye movement sleep.'5 Given intravenously (10 mg) it immediately reverses the deep sedation induced by intravenous flunitrazepam (2 mg) and the impaired per- Benzodiazepines are remarkably non-toxic. Taken alone, formance caused by intravenous midazolam.'6 Ro 15-1788 is even large doses rarely produce serious effects. Self almost devoid of intrinsic effects in oral doses of 600 mg,'3 poisoners commonly take mixtures of drugs, however, and though it may depress stage 4 sleep.'5 Electroencephalo- benzodiazepines are included in 40% of drug overdoses in graphic frequency analysis and evoked potentials both show Britain.' Because of additive effects large doses of benzo- a stimulant effect after intravenous Ro 15-1788 (5 mg); diazepines taken with other depressants may aggravate or some people report mild anxiety and "pressure to move,"'7 precipitate respiratory failure, especially in the elderly or suggesting slight inverse agonist activity. patients with pulmonary disease; they may also add to A few clinical trials of Ro 15-1788 in benzodiazepine hypotension and occasionally lead to fatal hypothermia in overdose have been reported. In one open study nine myxoedema.2 patients (aged 22-74) in deep coma due to benzodiazepines A patient suspected of having taken benzodiazepines with responded within one to two minutes to intravenous Ro 15- other drugs producing coma may present diagnostic 1788 (2-5-10 mg).'8 They opened their eyes and responded difficulties. -
Molecular Mechanisms of Antiseizure Drug Activity at GABAA Receptors
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Seizure 22 (2013) 589–600 Contents lists available at SciVerse ScienceDirect Seizure jou rnal homepage: www.elsevier.com/locate/yseiz Review Molecular mechanisms of antiseizure drug activity at GABAA receptors L. John Greenfield Jr.* Dept. of Neurology, University of Arkansas for Medical Sciences, 4301W. Markham St., Slot 500, Little Rock, AR 72205, United States A R T I C L E I N F O A B S T R A C T Article history: The GABAA receptor (GABAAR) is a major target of antiseizure drugs (ASDs). A variety of agents that act at Received 6 February 2013 GABAARs s are used to terminate or prevent seizures. Many act at distinct receptor sites determined by Received in revised form 16 April 2013 the subunit composition of the holoreceptor. For the benzodiazepines, barbiturates, and loreclezole, Accepted 17 April 2013 actions at the GABAAR are the primary or only known mechanism of antiseizure action. For topiramate, felbamate, retigabine, losigamone and stiripentol, GABAAR modulation is one of several possible Keywords: antiseizure mechanisms. Allopregnanolone, a progesterone metabolite that enhances GABAAR function, Inhibition led to the development of ganaxolone. Other agents modulate GABAergic ‘‘tone’’ by regulating the Epilepsy synthesis, transport or breakdown of GABA. GABAAR efficacy is also affected by the transmembrane Antiepileptic drugs chloride gradient, which changes during development and in chronic epilepsy. This may provide an GABA receptor Seizures additional target for ‘‘GABAergic’’ ASDs. GABAAR subunit changes occur both acutely during status Chloride channel epilepticus and in chronic epilepsy, which alter both intrinsic GABAAR function and the response to GABAAR-acting ASDs.